WellensH.J.. 1967–1997: Thirty years of cardiac arrhythmias.Eur Heart J1998; 19: 984–9.
2.
MirowskiM., ReidP.R., MowerM.M.. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings.N Engl J Med1980; 303: 322–5.
3.
The Antiarrhythmics versus Implantable Defibrillators (AVID)Investigators: a comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.N Engl J Med1997; 337: 1576–83.
4.
NaccarelliG.V., WolbretteD.L., Dell'OrfanoJ.T.. A decade of clinical trial developments in postmyocardial infarction, congestive heart failure and sustained ventricular tachyarrhythmia patients: from CAST to AVID and beyond.J Cardiovasc Electrophys1998; 9: 864–91.
5.
MossA.J., HallJ., CannomD.S.for Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implantable defibrillator in patients with coronary disease at high risk for ventricular arrhythmia.N Engl J Med1996; 335: 1933–44.
6.
BuxtonA.E., LeekL., FisherJ.D.for the MUSTT Investigators. A randomized study for the prevention of sudden death in patients with coronary artery disease.N Engl J Med1999; 341: 1882–90.
BorianiG., PergoliniF., BiffiM.. The follow up of the implantable patient: how to utilized the diagnostic systems for the corrected follow up. In: AdornatoE., ed. Rhythm control for cardiac evaluation to treatment.Roma: Ed. L. Pozzi, 1998; 452–8.
9.
RicciR., AzzoliniP., PuglisiA.. Consistent atrial pacing: can this new algorithm suppress recurrent paroxysmal atrial fibrillation?G Ital Cardiol1998; 28(suppl. 1): 115–8.
10.
BorianiG., BottoG.L., FrabettiL.. Does dual chamber pacing prevent paroxysmal atrial fibrillation in brady-tachy patients?G Ital Cardiol1998; 28(suppl. 1): 121–4.
11.
SaksenaS., PrakashA., HillM.. Prevention of atrial fibrillation with dual site right atrial pacing.J Am Coll Cardiol1996; 228: 687–94.
12.
GrasD., RitterP., LeclerqC.. Biatrial pacing for atrial arrhytmias prevention. In: SantiniM., ed. Progress in clinical pacing 1998.Futura: Armonk, 1998; 301–6.
13.
PadelettiL., PorcianiM.C., MichelucciA.. Interatrial septal pacing; a new approach to prevent paroxysmal atrial fibrillation.J Interv Card Electrophysiol1999; 3: 35–43.
14.
LevyS., RicardP., LauC P.. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation.J Am Coll Cardiol1997; 29: 750–5.
15.
SantiniM., PandoziC., ToscanoS.. Changes in intracardiac atrial cardioversion at rest and during exercise.J Am Coll Cardiol1997; 29: 576–81.
16.
BorianiG., BiffiM., BronzettiG.. Efficacy and tolerability in fully conscious patients of transvenous low energy internal atrial cardioversion for atrial fibrillation.Am J Cardiol1998; 81: 241–4.
17.
LermanB., SteinK., MarkowitzS.. Worldwide clinical experience with the model 7250 Jewel AF due chamber arrhythmia management device (Abstract).PACE1998; 21: 872.
18.
ProclemerA., FacchiniD.. Which ICD for which patient? In: AdornatoE., ed. Rhythm control from cardiac evaluation to treatment.Roma: Ed. L. Pozzi, 1998; 429–34.
19.
BestP.J., HayesD.L., StantonM.S.. The potential usage of dual chamber pacing in patients with ICDs.PACE1999; 22: 79–85.
LombardiF., MarzegalliM., MarchiniA.. Linear and non linear dynamics characterize heart rate variability before the onset of VT in patient with ICD (Abstract).PACE1998; 21: 927.
27.
BorianiG., FrabettiL., BiffiM.. First use of a new follow up procedure for implantable cardioverter defibrillators made user friendly (Abstract).Arch Mal Coeur1998; 91: 262.